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Abstract Extraversion is a relatively stable and heritable
personality trait associated with numerous psychosocial,
lifestyle and health outcomes. Despite its substantial heri-
tability, no genetic variants have been detected in previous
genome-wide association (GWA) studies, which may be
due to relatively small sample sizes of those studies. Here,
we report on a large meta-analysis of GWA studies for
extraversion in 63,030 subjects in 29 cohorts. Extraversion
item data from multiple personality inventories were har-
monized across inventories and cohorts. No genome-wide
significant associations were found at the single nucleotide
polymorphism (SNP) level but there was one significant hit
at the gene level for a long non-coding RNA site
(LOC101928162). Genome-wide complex trait analysis in
two large cohorts showed that the additive variance
explained by common SNPs was not significantly different
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from zero, but polygenic risk scores, weighted using link-
age information, significantly predicted extraversion scores
in an independent cohort. These results show that
extraversion is a highly polygenic personality trait, with an
architecture possibly different from other complex human
traits, including other personality traits. Future studies are
required to further determine which genetic variants, by
what modes of gene action, constitute the heritable nature
of extraversion.
Keywords Personality  Phenotype harmonization 
Common genetic variants  Imputation  Polygenic risk
Introduction
Extraversion is a personality trait characterized by the
tendency to experience positive emotions, to be active and
feel energetic, to be talkative and to enjoy social interac-
tions. Extraversion is associated with numerous psy-
chosocial, lifestyle and health outcomes, such as academic
and job performance, well-being, obesity, substance use,
physical activity, bipolar disorder, borderline personality
disorder, Alzheimer’s disease, and longevity (De Moor
et al. 2006, 2011; Distel et al. 2009a; Furnham et al. 2013;
Judge et al. 2013; Middeldorp et al. 2011; Rhodes and
Smith 2006; Sutin et al. 2011; Terracciano et al. 2008;
Terracciano et al. 2014; Weiss et al. 2008).
Extraversion can be measured with multiple inventories
that have been developed as part of different personality
theories. For example, extraversion is one of the five per-
sonality domains as assessed with the Neuroticism–Ex-
traversion–Openness to Experience (NEO) personality
inventories (Costa and McCrae 1992). Extraversion is also
included in Eysenck’s three-dimensional theory of per-
sonality (Eysenck and Eysenck 1964, 1975; Eysenck et al.
1985). In Cloninger’s theory on temperaments and char-
acters (Cloninger 1987; Cloninger et al. 1993), Harm
Avoidance, Novelty Seeking and Reward Dependence are
related to extraversion (De Fruyt et al. 2000). Tellegen’s
personality theory posits the higher order domain of Posi-
tive Emotionality (Patrick et al. 2002), which resembles
and is highly correlated with extraversion (Church 1994).
We showed recently, by performing an Item Response
Theory (IRT) analysis using test linking (Kolen and
Brennan 2004), that item data on Extraversion, Reward
dependence and Positive Emotionality can be harmonized
to broadly assess the same underlying extraversion con-
struct (van den Berg et al. 2014). This harmonization was
performed in over 160,000 individuals from 23 cohorts
participating in the Genetics of Personality Consortium
(GPC). Briefly, harmonization was carried out in each
cohort separately by first fitting an IRT model to data from
39 Department of Psychiatry and Behavioral Neuroscience,
University of Chicago, Chicago, USA
40 Department of Biostatistics and Bioinformatics, Duke
University, Durham, NC, USA
41 National Institute for Health and Welfare (THL), Helsinki,
Finland
42 Department of General Practice and Primary Health Care,
University of Helsinki, Helsinki, Finland
43 Unit of General Practice and Primary Health Care, University
of Helsinki, Helsinki, Finland
44 Vasa Central Hospital, Vaasa, Finland
45 Interfaculty Institute for Genetics and Functional Genomics,
University of Greifswald, Greifswald, Germany
46 Translational Research Institute, University of Queensland
Diamantina Institute, Brisbane, Australia
47 Department of Molecular and Translational Medicine,
University of Brescia, Brescia, Italy
48 Department of Biotechnology, University of Tartu, Tartu,
Estonia
49 Department of Psychiatry, EMGO? Institute, Neuroscience
Campus Amsterdam, VU University Medical Center,
Amsterdam, The Netherlands
50 Institute of Clinical Chemistry and Laboratory Medicine,
University Medicine Greifswald, Greifswald, Germany
51 Wellcome Trust Sanger Institute, Wellcome Trust Genome
Campus, Hinxton, Cambridge, UK
52 Institute for Molecular Medicine Finland (FIMM), University
of Helsinki, Helsinki, Finland
53 Department of Public Health, Faculty of Medicine,
University of Split, Split, Croatia
54 Department of Clinical Physiology and Nuclear Medicine,
Turku University Hospital, Turku, Finland
55 Research Centre of Applied and Preventive Cardiovascular
Medicine, University of Turku, Turku, Finland
56 Department of Psychological & Brain Sciences, Indiana
University, Bloomington, IN, USA
57 Department of Psychological Sciences and Missouri
Alcoholism Research Center, University of Missouri,
Columbia, MO, USA
58 Alzheimer Scotland Dementia Research Centre, University of
Edinburgh, Edinburgh, UK
59 School of Oral and Dental Sciences, University of Bristol,
Bristol, UK
60 School of Experimental Psychology, University of Bristol,
Bristol, UK
61 College of Medicine, Florida State University, Tallahassee,
FL, USA
172 Behav Genet (2016) 46:170–182
123
individuals who had completed at least two different per-
sonality questionnaires. Next, based on calibrated item
parameters, personality scores were estimated based on all
available data for each individual, irrespective of what
personality questionnaire was used. The harmonized
extraversion phenotype was heritable. A broad-sense heri-
tability of 49 % was estimated, based on a meta-analysis in
six twin cohorts that are included in the GPC (29,501 twin
pairs), of which 24 % was due to additive genetic variance
and 25 % due to non-additive genetic variance. The broad-
sense heritability estimate is similar to heritability esti-
mates obtained for extraversion as assessed with single
measurement instruments (Bouchard and Loehlin 2001;
Distel et al. 2009b; Finkel and McGue 1997; Keller et al.
2005; Rettew et al. 2008; Yamagata et al. 2006). Some
evidence for qualitative sex differences in the genetic
influences on extraversion was suggested by a genetic
correlation in opposite-sex twin pairs of 0.38 (van den Berg
et al. 2014). Extraversion becomes more genetically stable
during adolescence until it is almost perfectly genetically
stable in adulthood (Briley and Tucker-Drob 2014; Kandler
2012), that is, the same genes are responsible for
extraversion measured at different ages.
A handful of genome-wide association (GWA) studies for
extraversion have been published, aimed at detecting
specific single nucleotide polymorphisms (SNPs) that
explain part of the heritability. The first GWA study for
personality, which focused on the five NEO personality
traits, was conducted in 3972 adults (Terracciano et al.
2010). No genome-wide significant SNP associations were
found for extraversion, although some interesting associa-
tions with P-values \10-5 were seen with SNPs in two
cadherin genes and the brain-derived neurotrophic factor
(BDNF) gene. A subsequent meta-analysis of GWA results
for the NEO personality traits, conducted in 17,375 subjects,
also did not yield any genome-wide significant associations
for extraversion (De Moor et al. 2012). Two other GWA
studies reported a similar lack of genome-wide significance
for Cloninger’s temperament scales (Service et al. 2012;
Verweij et al. 2010). Interestingly, a study that performed a
genetic complex trait analysis (GCTA; Yang et al. 2010) for
neuroticism and extraversion in around 12,000 unrelated
individuals reported that 12 % (SE = 3 %) of the variance
in extraversion was explained by common SNPs of additive
effect (Vinkhuyzen et al. 2012). Taken together, the results
from twin and genome-wide studies suggest that common
SNPs of additive effect are important, that genetic non-ad-
ditivity may play a role, and that large sample sizes are likely
to be required to identify specific variants.
In this paper, we report the results of the largest meta-
analysis of GWA results for extraversion so far, carried out
in 29 cohorts that participate in the GPC. A total of 63,030
subjects with harmonized extraversion and genome-wide
genotype data were included in the meta-analysis. A 30th
cohort was used for replication. In this consortium we
reported earlier on a genome-wide significant hit for neu-
roticism (De Moor et al. 2015), indicating that we may
begin to analyze data from sufficiently large samples, to
obtain the first significant findings from GWA studies for
personality. In addition to meta-analysis of GWA results,
we computed weighted polygenic scores in an independent
cohort and associated them with extraversion, and esti-
mated variance explained by SNPs in two large cohorts.
Materials and methods
Cohorts
The full meta-analysis was performed on 63,030 subjects
from 29 discovery cohorts. All samples were of European
origin. Twenty-one cohorts were from Europe, six from the
United States and two from Australia. Sample sizes of the
individual cohorts ranged from 177 to 7210 subjects. Please
note that some cohorts were also part of previously published
GWA studies on extraversion. The Generation Scotland:
Scottish Family Health Study (GS:SFHS) cohort was
included as a replication sample (9,783 subjects). A brief
overview of all cohorts is provided in Table 1. A description
of each individual cohort is found in the Supplementary
materials and methods (see also De Moor et al. 2015).
Phenotyping
A harmonized latent extraversion score was estimated for
all participants in all 29 cohorts that were included in the
GWA meta-analysis. This score was based on all available
extraversion item data for each individual (for a detailed
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description see van den Berg et al. 2014). Extraversion
item data came from the extraversion scales of the NEO
Personality Inventory, the NEO Five Factor Inventory, the
50-item Big-Five version of the International Personality
Item Pool inventory, the Eysenck Personality Question-
naire and the Eysenck Personality Inventory, from the
Reward Dependence scale of the Cloninger’s Tridimen-
sional Personality Questionnaire, and from the Positive
Emotionality scale of the Multidimensional Personality
Questionnaire (see van den Berg et al. 2014 and Supple-
mentary materials and methods). In the GS:SFHS cohort
that was included for replication of top signals, extraver-
sion was based on the summed score of the extraversion
scale of the EPQ Revised Short Form.
Genotyping and imputation
Genotyping in all cohorts was carried out on Illumina or
Affymetrix platforms, after which quality control (QC) was
performed, followed by imputation of genotypes. QC of
genotype data was performed in each cohort separately,
with comparable but cohort specific criteria. Standard QC
checks included tests of European ancestry, sex inconsis-
tencies, Mendelian errors, and high genome-wide
homozygosity. Checks for relatedness were conducted in
those cohorts that aimed to include unrelated individuals
only. Other checks of genotype data were based on minor
allele frequencies (MAF), SNP call rate (% of subjects with
missing genotypes per SNP), sample call rate (% of miss-
ing SNPs per subject) and Hardy–Weinberg Equilibrium
(HWE). Genotype data were imputed using the 1000Gen-
omes phase 1 version 3 (build37, hg19) reference panel
with standard software packages such as IMPUTE, MACH,
or Minimac, see Supplementary Table 1.
Statistical analyses
GWA analysis per cohort
GWA analyses were conducted independently in each
cohort. Since the cohorts used different research designs
(case–control, population twin studies, extended pedigrees,
etc.), GWA methods were optimized for each cohort.
Extraversion scores were regressed on each SNP under an
additive model, with sex and age included as covariates.
Covariates such as ancestry Principal Components (PCs)
were added if deemed necessary for a particular cohort. In
all analyses, the uncertainty of the imputed genotypes was
taken into account, either using dosage scores or mixtures
of distributions. In those cohorts that included related
individuals, the dependency among participants was
accounted for using cohort-specific methods. Standard
software packages for GWA analyses were used (see
Supplementary Table 1).
Meta-analysis of GWA results across cohorts
A meta-analysis of the GWA results was conducted
with the weighted inverse variance method in METAL
(http://www.sph.umich.edu/csg/abecasis/metal/index.html).
Excluded from meta-analysis were poorly imputed SNPs
(r2\ 0.30 or proper_info\ 0.40) and SNPs with low
Table 1 Overview of 29 discovery cohorts and 1 replication cohort
of the Genetics of Personality Consortium
Cohort # Subjectsa # SNPsb
1 ALSPAC 4705 6,454,153
2 BLSA 820 4,989,411
3 BRESCIA 177 3,549,919
4 CHICAGO 311 3,755,416
5 CILENTO 627 1,123,089
6 COGA 647 5,127,101
7 COGEND 1279 5,932,838
8 EGCUT 1184 5,574,695
9 ERF 2300 5,142,865
10 FTC EPI 567 4,870,096
11 FTC NEO 813 5,092,018
12 HBCS 1456 5,612,790
13 CROATIA-Korcula 808 5,094,034
14 LBC1921 437 4,363,611
15 LBC1936 952 5,168,754
16 MCTFR 7099 6,569,999
17 MGS 2101 5,900,898
18 NBS 1832 5,603,447
19 NESDA 2227 4,707,569
20 NTR 6416 5,339,798
21 ORCADES 1650 4,265,590
22 PAGES 476 4,547,293
23 QIMR adolescents 2842 5,957,064
24 QIMR adults 7210 6,343,920
25 SardiNIA 4332 6,291,135
26 SHIP 2213 5,913,428
27 STR 4903 6,519,094
28 CROATIA-Vis 909 5,327,671
29 YFS 1737 5,914,679
Total 63,030 7,460,147
30 GS:SFHS 9783 74
NA Not Applicable for replication cohort because only top hits were
sought to replicate
a Number of subjects with valid latent score for Extraversion and
SNP data (after imputation and cleaning)
b Number of SNPs (after imputation and cleaning) with valid asso-
ciation results that entered the meta-analysis
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MAF (MAF\H(5/N), which corresponds to less than 5
estimated individuals in the least frequent genotype group,
under the assumption of HWE). This resulted in a total
number of 7,460,147 unique SNPs in the final meta-anal-
ysis (with 1.1–6.6 M SNPs across cohorts). For 2182 SNPs,
SNP locations could not be matched with rs names. For an
additional 516,362 SNPS, results were based on one cohort
only and therefore left out of the analysis, so that the results
are based on 6,941,603 SNPs. Genomic control inflation
factors (lambda), Manhattan plots and quantile–quantile
plots per cohort are provided in Supplementary Table 2
and Supplementary Figs. 1, 2. A P value of 5 9 10-8 was
used as the threshold for genome-wide significance.
The meta-analysis results (P-values per SNP) were used
as the input to compute P-values at the gene level. We
performed these analyses in KGG (Li et al. 2012). A P-
value of 2.87 9 10-6 was used as the threshold for gen-
ome-wide significance in these gene-wide analyses, based
on controlling for the false-discovery rate (Benjamini and
Hochberg 1995).
All GWAS SNP top hits with a P-value smaller than
1 9 10-5 were selected for replication in the GS:SFHS
cohort.
Polygenic risk score analysis
Additional analyses were conducted to test whether
extraversion could be predicted in an independent target
cohort based on the GWA meta-analysis results. The target
cohort was the Netherlands Twin Register (NTR) cohort
(8648 subjects). Polygenic risk scores for this cohort were
estimated using LDpred (Vilhjalmsson et al. 2015) that
takes into account linkage disequilibrium among the SNPs.
The estimation was based on a GWA meta-analysis in
which the NTR and NESDA cohorts were excluded (fur-
ther referred to as the discovery set). With the LD-cor-
rected polygenic risk scores, generalized estimating
equation (GEE) modeling was applied to test whether the
polygenic risk scores predicted extraversion in the target
cohort. The covariates age, sex and ten PCs were included
as fixed effects in the model. The model also included a
random intercept with family number as the cluster vari-
able, to account for dependency among family members.
Outliers on the PCs, including ethnic outliers, were
excluded from the analysis.
Variance explained by SNPs
In the NTR cohort and the QIMR Berghofer Medical
Research Institute (QIMR) adult cohort (see also Supple-
mentary materials and methods), GCTA software (Visscher
et al. 2010; Yang et al. 2010) was used to estimate the
proportion of variance in extraversion that can be explained
by common SNPs of additive effect. In the NTR, this
analysis was carried out in a set of 3597 unrelated indi-
viduals and in the QIMR adult cohort this was done in 3369
unrelated individuals (in each cohort one member per
family was selected with harmonized extraversion and
genome-wide SNP data). GCTA analysis was based on best
guess genotypes obtained in PLINK using a threshold of a
maximum genotype probability [0.70, and additionally
filtering on r-squared[0.80. Next, in estimating the GRM
matrix in the GCTA software, SNPs with MAF\0.05 were
excluded. The additive genetic relationship matrices
(GRM) estimated based on SNPs for all individuals formed
the basis to estimate the proportion of phenotypic variance
explained by SNPs in the NTR and QIMR cohorts. In other
words, it was determined to what extent phenotypic simi-
larity between individuals corresponds to genetic similarity
(at the SNP level). For both NTR and QIMR, sex, age and a
set of population-specific PCs were included as covariates.
Results
Meta-analysis of GWA results
Meta-analysis of GWA results across the 29 discovery
cohorts did not yield genome-wide significant SNPs asso-
ciated with extraversion. The lowest P-value observed was
2.9 9 10-7 for a SNP located on chromosome 2. There
were 74 SNPs with P-values \1 9 10-5. The Manhattan
and quantile–quantile plots are provided in Figs. 1 and 2. A
list with the top five SNPs is given in Table 2. A list with
all SNPs that reached the level of suggestive genome-wide
significance (P\ 1 9 10-5) is found in Supplementary
Table 3. The results of all SNPs can be downloaded from
www.tweelingenregister.org/GPC. A gene-based test
showed one significant hit for LOC101928162, a long non-
coding RNA site, P = 2.87 9 10-6. A list with the top five
genes from the gene-based analysis is provided in Table 3.
Supplementary Table 4 provides the top 30 genes. Among
the top 30 genes was Brain-Derived Neurotrophic Factor
(BDNF, P = 0.0003), a gene also implicated, though not
genome-wide significant, in Terracciano et al. (2010), as
was the BDNF anti-sense RNA gene (P = 0.0001).
Results of the follow-up analysis of the top five SNPs in
the GS:SFHS cohort can be found in Table 2. Of the top
five SNPs, none showed a significant effect. For an over-
view of the replication results of all top SNPs with P-value
\1 9 10-5 see Supplementary Table 3. Of the 74 SNPs
tested in the replication cohort, three SNPs showed nomi-
nal evidence of association (P\ 0.05), which is less than
the number expected based on chance alone
(0.05 9 74 = 3.7).
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Polygenic risk score analysis
There were 8201 persons individuals with polygenic scores
for prediction of extraversion. The LDpred-based genetic
risk scores significantly predicted extraversion in the target
cohort, B = 0.059, X2(1) = 27.30, P\ 0.001.
Variance explained by SNPs
In the NTR cohort, an estimated 5.0 % (SE = 7.2) of the
variance in extraversion was explained by all SNPs, but
this estimate was not significantly different from zero
(P = 0.24). In the QIMR cohort, 0.0001 % (SE = 15) of
the variance was explained by SNPs (P = 0.46).
Discussion
This study assessed the influence of common genetic
variants on extraversion in 63,030 individuals from 29
cohorts in the GPC. First, a meta-analysis of GWA anal-
yses across 29 discovery cohorts showed no genome-wide
significant SNPs. Top SNPs detected in the meta-analysis
of GWA results in the discovery phase were not replicated
in the GS:SFHS cohort. The SNPs with lowest P-values
have no previously reported relationship with personality,
psychopathology or brain functioning. Polygenic risk
scores based on the meta-analysis results predicted
extraversion in an independent data set. SNP-based
Fig. 1 Manhattan plot for meta-analysis results of 29 discovery cohorts for extraversion in the Genetics of Personality Consortium
Fig. 2 Quantile-Quantile plots for meta-analysis results of 29
discovery cohorts for extraversion in the Genetics of Personality
Consortium
Table 2 Top SNPs from the meta-analysis of GWA results in 29 discovery cohorts for extraversion, and their replication in the GS:SFHS
cohort, in the Genetics of Personality Consortium
SNP Chr_BP Alleles Closest gene Discovery results Replication results
Effect SE P-value Effect SE P-value
rs2024488 2_217662968 A/G LOC101928250 -0.0303 0.0059 2.939 x 10-7 0.0285 0.0164 0.08244
rs2712162 2_217661788 T/C LOC101928250 -0.0300 0.0059 3.872 x 10-7 0.0278 0.0164 0.08947
rs797182 12_10900487 A/G \NA[ -0.0277 0.0056 6.673 x 10-7 -0.0135 0.0153 0.37721
rs8010306 14_37150160 A/G SLC25A21 0.0629 0.0128 8.730 x 10-7 0.0180 0.0314 0.56650
rs117292860 19_2227621 A/C DOT1L 0.0553 0.0113 9.191 x 10-7 -0.0350 0.0239 0.14368
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heritabilities for extraversion were not significantly dif-
ferent from zero in two large cohorts of the GPC.
Although there were no genome-wide significant results
for individual SNPs, in the gene-based analysis, there was
a significant hit for one locus, LOC101928162. This is
long noncoding RNA site whose function remains elusive.
Interestingly, among the top 30 genes were genes previ-
ously implicated in extraversion or in psychiatric disorders
associated with extraversion. The low P-value for
CRTAC1 (P = 2.97 x 10-5), harks back to an interesting
extraversion SNP (rs7088779) in a previous GWAS on
personality (Amin et al. 2013) that is located
between CRTAC1 and C10orf28. RELN (P = 5.69 x 10-5)
has been reported to increase the risk for schizophrenia and
bipolar disorder (Kuang et al. 2011; Ovadia and Shifman
2011), while ADAM12 (7.65 x 10-5) was previouslyfound
to be involved in schizophrenia (Farkas et al. 2010),
and bipolar disorder treatment (Nadri et al.
2007). The BDNF gene was also implicated in a previous
extraversion GWAS (Terracciano et al. 2010), though not
genome-wide significant. Liu et al. (2005) reported a trend
towards association of BDNF variants with substance
abuse, Jiao et al. (2011) reported an association with obe-
sity, and Lang et al. (2007) and Beuten et al. (2005) re-
ported associations with smoking behavior. As
extraversion is known to be associated with lifestyle,
obesity and substance abuse, we deem BDNF to be an
interesting candidate gene for extraversion in future stud-
ies, along with CRTAC, ADAM12 and RELN.
With the current meta-analysis we more than tripled the
sample size as compared to the largest previously published
meta-analysis for extraversion (De Moor et al. 2012). In
contrast to neuroticism, no genome-wide significant SNPs
were found. Some have argued (Turkheimer et al. 2014) that
the heritability of personality traits represents nonspecific
genetic background, which is composed of so many genetic
variants with extremely small effect sizes that individually
these have no causal biological interpretation. It may be that
extraversion differs in this respect from neuroticism. One
other difference was indicated from the analyses of the IRT-
based extraversion and neuroticism scores: whereas for
neuroticism no evidence for genotype x sex interaction was
seen (van den Berg et al. 2014), for extraversion there was
significant evidence for sex limitation. It also is interesting to
note that despite the fact that for extraversion no genome-
wide significant findings emerged for single SNPs, we were
able to predict extraversion in an independent dataset, based
on the polygenic risk cohorts from the discovery set. This
indicates that some true signal is entailed in the meta-anal-
ysis results.
The results of the polygenic risk score analysis are in
contrast with the results from the GCTA analysis, in which
no significant proportion of variance explained by SNPs
was detected in two large cohorts of the GPC. Our study on
neuroticism reported a SNP-based heritability of 15 % (De
Moor et al. 2015). The current extraversion GCTA findings
are also somewhat at odds with two previous GCTA studies
for personality traits. One study focused on neuroticism
and extraversion as measured with different instruments in
four cohorts, and found on average 12 % explained vari-
ance for extraversion, although across cohorts these esti-
mates varied widely (0–27 %) (Vinkhuyzen et al. 2012).
Estimates for neuroticism also varied, but were generally
lower than for extraversion in this study, with an average of
6 % explained variance. In another study, between 4.2 and
9.9 % of explained variances were found for the four
Cloninger temperaments in a combined sample of four
cohorts (Verweij et al. 2012). The proportions of variances
for Harm Avoidance, Novelty Seeking and Persistence
were significant at P\ 0.05, whereas interestingly the
proportion of variance for Reward Dependence was not. It
should be noted that both these studies included the QIMR
cohort in their analyses, so there is some overlap in sub-
jects across studies. The difference is that in the earlier
studies extraversion and reward dependence were based on
single personality inventories, while in our study
extraversion scores harmonized among different personal-
ity inventories were analyzed. What our results and the
results in the previous studies have in common though, is
that the estimates are considerably smaller than the heri-
tability estimates based on twin studies. Given that about
half of the heritability of extraversion consists of non-ad-
ditive genetic variance (van den Berg et al. 2014), it is not
unlikely that this discrepancy is caused by the influence of
Table 3 Top genes from the meta-analysis of GWA results in 29 discovery cohorts for Extraversion in the Genetics of Personality Consortium
Gene Full gene name Pathways P-value
LOC101928162 [Long non-coding RNA] Unknown 0.00000287
LOC729506 [Long non-coding RNA] Unknown 0.00000893
PLEKHJ1 Pleckstrin Homology Domain Containing, Family J
Member 1
Phospholipid binding, circadian clock
functioning
0.0000132
POU2F3 POU Class 2 Homeobox 3 Influenza A 0.0000179
CRTAC1 Cartilage Acidic Protein 1 Unknown 0.0000297
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common variants that interact within loci (dominance) or
across loci (epistasis). In addition, the influence of rare
variants may be implicated. The relatively limited influ-
ence of common additive genetic variation, as well as a
previously reported finding that higher levels of inbreeding
are associated with less socially desirable personality trait
levels, has led to the idea that the genetic variation in
personality traits may have been maintained by mutation–
selection balance (Verweij et al. 2012), and our results are
consistent with this idea.
This study comes with some limitations. Genotyping,
QC, and imputation were carried out separately in each
cohort. Any difference in procedures may have caused
some loss of statistical power to detect SNPs in the meta-
analysis. Similarly, extraversion item data were harmo-
nized as much as possible (van den Berg et al. 2014), but
the Reward Dependence item data from the TCI were least
successfully linked to the extraversion data from the other
inventories. This may also have caused some loss in power.
Importantly however, it should be noted that by combining
genotype and phenotype data across cohorts as performed
in this study, a substantial increase in sample size was
obtained. It is nontrivial that the gain in power associated
with this increase in sample size largely outweighs any
potential loss in power due to any remaining genotyping or
phenotyping differences across cohorts.
In conclusion, extraversion is a heritable, highly poly-
genic personality trait with a genetic background that may
be qualitatively different from that of other complex
behavioral traits. Future studies are required to increase our
knowledge of which types of genetic variants, by which
modes of gene action, constitute the heritable nature of
extraversion. Ultimately, this knowledge can be used to
increase our understanding of how extraversion is related
to various important psychosocial and health outcomes.
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